The DOI matches its Crossref record; 242 of the 244 references it cites were found in a registry or an index.
Alcoholic liver disease
Abstract
Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease worldwide. ALD can progress from alcoholic fatty liver (AFL) to alcoholic steatohepatitis (ASH), which is characterized by hepatic inflammation. Chronic ASH can eventually lead to fibrosis and cirrhosis and in some cases hepatocellular cancer (HCC). In addition, severe ASH (with or without cirrhosis) can lead to alcoholic hepatitis, which is an acute clinical presentation of ALD that is associated with liver failure and high mortality. Most individuals consuming >40 g of alcohol per day develop AFL; however, only a subset of individuals will develop more advanced disease. Genetic, epigenetic and non-genetic factors might explain the considerable interindividual variation in ALD phenotype. The pathogenesis of ALD includes hepatic steatosis, oxidative stress, acetaldehyde-mediated toxicity and cytokine and chemokine-induced inflammation. Diagnosis of ALD involves assessing patients for alcohol use disorder and signs of advanced liver disease. The degree of AFL and liver fibrosis can be determined by ultrasonography, transient elastography, MRI, measurement of serum biomarkers and liver biopsy histology. Alcohol abstinence achieved by psychosomatic intervention is the best treatment for all stages of ALD. In the case of advanced disease such as cirrhosis or HCC, liver transplantation may be required. Thus, new therapies are urgently needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic and excessive alcohol intake is known to cause liver injury from mild steatosis (simple fat accumulation in so-called alcoholic fatty liver disease, AFLD) to more advanced liver disease such as inflammation (alcoholic steatohepatitis, ASH), fibrosis/cirrhosis, hepatic cancer, liver failure, and death203–213.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [212]
Citations
Cites
1 retracted
Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells
Chen, C., Tsukamoto, H., Liu, J.-C., Kashiwabara, C., Feldman, D. E., Sher, L. S., Dooley, S., French, S. W., Mishra, L., Petrovic, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65859 · Cited by 161
Self-citationRetractedDiagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
Bush, K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1789 · Cited by 6,196
Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2017) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,107
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Research works printed but not linked: 4
- Pone, E. J. Toll-like receptors. Signal. Pathways Liver Diseases 1390, 149–159 (2016).
- French, S. W. & Bardag-Gorce, F. in Signaling Pathways in Liver Diseases (eds Dufour, J.-F. et al.) 377–389 (Springer, 2005).
- Thiele, M. et al. Controlled attenuation parameter and alcoholic hepatic steatosis: diagnostic accuracy and role of alcohol detoxification. J. Hepatol. 68, 1025–1032 (2018). · DOI
- [No authors listed.]. Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1, 707–711 (1981).
Cited by
Sorted by citations
Items 601–700 of 999
Kang, L., Xia, C., Ma, S., Gao, Z., Su, Z., Li, X., Zhao, Y., Guo, J., & Li, G. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123619 · Cited by 11
Phage therapy: A novel approach to combat drug-resistant pathogens
Yao, M., Zhu, Y., Duan, J., & Xiao, P. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128228 · Cited by 15
Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease
Ding, Q., Cao, F., Zhuge, H., Lai, S., Cao, W., Wei, H., Guo, R., Qiu, J., Song, Q., Pei, L., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt6195 · Cited by 11
Hebbani, A. V., Vaddi, D. R., Padma Priya, D. D., & N.Ch, V. (2021) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2021.02.001 · Cited by 11
Bogliotti, Y. S., Roest, M. V., Mattis, A. N., Gish, R. G., Peltz, G., Anwyl, R., Kivlighn, S. D., & Schuur, E. R. (2022) · Cells · doi:10.3390/cells11131998 · Cited by 11
Jiang, T., Xu, J., Yang, L., Chen, X., & Li, Y. (2022) · Mediators of Inflammation · doi:10.1155/2022/1708030 · Cited by 11
Myeloid cells in alcoholic liver diseases: Mechanism and prospect
Xu, W., Wu, M., Chen, B., & Wang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.971346 · Cited by 11
Guo, R., Chen, L., Zhu, J., Li, J., Ding, Q., Chang, K., Han, Q., & Li, S. (2023) · Food & Function · doi:10.1039/d2fo03323b · Cited by 11
Examining the interim proposal for name change to steatotic liver disease in the US population
Ng, C. H., Chan, K. E., Muthiah, M. D., Tan, C., Tay, P. W. L., Lim, W. H., Tan, D. J. H., Fu, C. E., Yong, J. N., Wong, Z. Y., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000043 · Cited by 11
Kharbanda, K. K., Chokshi, S., Tikhanovich, I., Weinman, S. A., New‐Aaron, M., Ganesan, M., & Osna, N. A. (2023) · Biology · doi:10.3390/biology12020255 · Cited by 11
Current and emerging therapies for alcohol-associated hepatitis
Idalsoaga, F. J., Ayares, G., Díaz, L. A., Arnold, J., Ayala-Valverde, M., Hudson, D., Arrese, M. A., & Arab, J. P. (2023) · Liver Research · doi:10.1016/j.livres.2023.03.002 · Cited by 11
Winder, G. S., Clifton, E. G., Fernandez, A. C., MacEachern, M., Andrews, S. R., Perumalswami, P., DiMartini, A. F., & Mellinger, J. L. (2023) · Liver Transplantation · doi:10.1097/lvt.0000000000000144 · Cited by 11
Queck, A., Fink, A. F., Sirait‐Fischer, E., Rüschenbaum, S., Thomas, D., Snodgrass, R. G., Geißlinger, G., Baba, H. A., Trebicka, J., Zeuzem, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01447 · Cited by 11
Yao, J., Yang, H., Wang, H., Shi, H., Yan, J., Zhang, Y., Chen, D., & Shi, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865389 · Cited by 11
Balbinot, P., Leone, S., Testino, G., & Caputo, F. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.12.002 · Cited by 11
Martínez-Ruiz, S., Badı́a, J., & Baldomà, L. (2025) · Nutrients · doi:10.3390/nu17193066 · Cited by 10
IL-1 family of cytokines in gastrointestinal and liver disorders
Schwärzler, J., Menghini, P., Dinarello, C. A., Cominelli, F., & Tilg, H. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01141-0 · Cited by 11
The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential
Li, L., Li, X., & Zhang, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694582 · Cited by 13
Iturrospe, E., Robeyns, R., Silva, K. M., Lavoir, M. C. A., Boeckmans, J., Vanhaecke, T., Nuijs, A. L. N., & Covaci, A. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03470-y · Cited by 8
Hardesty, J., Hawthorne, M., Day, L. Z., Warner, J. B., Warner, D. R., Gritsenko, M., Asghar, A., Stolz, A., Morgan, T. R. M., McClain, C. J., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000393 · Cited by 10
MLKL deficiency alleviates acute alcoholic liver injury via inhibition of NLRP3 inflammasome
Shen, Y., Chen, D., Linghu, M., Huang, B., Xu, S., Li, L., Lu, Y., & Li, X. (2024) · Toxicology · doi:10.1016/j.tox.2024.153864 · Cited by 10
Zhang, J., Li, Y., Liu, Y., Ma, N., Qian, S., Chen, Y., Duan, Y., Xiang, X., & He, Y. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01267-9 · Cited by 10
Lucas, M. R., Pilling, L. C., Atkins, J. L., & Melzer, D. R. (2024) · Hepatology · doi:10.1097/hep.0000000000001056 · Cited by 10
Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function
Sun, Y., Wu, Y., Li, M.-R., Wei, Y.-Y., Guo, M. L., & Zhang, Z. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i43.4660 · Cited by 10
Wang, M., Zhao, L., Wang, Y., Zhang, C., & Li, H. (2025) · Nutrients · doi:10.3390/nu17091589 · Cited by 10
Elgendy, S. A., Baloza, S. H., Mohammed, L. A., Nasr, H. E., El-Shaer, N. O., Ghamry, H. I., Althobaiti, S. A., Shukry, M., Soliman, M. M., & Elnoury, H. A. (2022) · Life · doi:10.3390/life12101671 · Cited by 10
Thomes, P. G., Strupp, M. S., Donohue, T. M., Kubik, J. L., Sweeney, S. A., Mahmud, R., Schott, M. B., Schulze, R. J., McNiven, M. A., & Casey, C. A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103071 · Cited by 10
Raman scattering-based optical sensing of chronic liver diseases
Alkhuder, K. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103505 · Cited by 12
Zhang, N., Xue, F., Wu, X., Zhang, W., Hou, J., Xiang, J., Lv, Y., & Zhang, X. (2023) · Alcohol and Alcoholism · doi:10.1093/alcalc/agad046 · Cited by 11
Kang, D. E., & Oh, S. N. (2023) · Nutrients · doi:10.3390/nu15183901 · Cited by 10
Hepatocellular carcinoma clinical update: Current standards and therapeutic strategies
Colquhoun, S. D. (2020) · Liver Research · doi:10.1016/j.livres.2020.11.004 · Cited by 11
Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
Yoshimura, Y., Hamaguchi, M., Hashimoto, Y., Okamura, T., Nakanishi, N., Obora, A., Kojima, T., & Fukui, M. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01893-4 · Cited by 10
Coral Hydrate, a Novel Antioxidant, Improves Alcohol Intoxication in Mice
Wu, H., Chao, T., Ou, H., & Tsai, L. (2022) · Antioxidants · doi:10.3390/antiox11071290 · Cited by 10
Shinoda, H., Watanabe, Y., Fukai, K., Kasuya, K., Furuya, Y., Nakazawa, S., Honda, T., Hayashi, T., Nakagawa, T., Tatemichi, M., et al. (2023) · European journal of medical research · doi:10.1186/s40001-022-00976-6 · Cited by 9
Zhao, J., Li, J., Zhang, X., Shi, S., Wang, L., Yuan, M., Liu, Y., & Wang, Y. (2023) · Molecules · doi:10.3390/molecules28041932 · Cited by 9
Hoebinger, C., Rajcic, D., Silva, B., & Hendrikx, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1148827 · Cited by 9
Wang, X., Liu, B., Liu, Y., Wang, Y., Wang, Z., Song, Y., Xu, J., & Xue, C. (2023) · Lipids · doi:10.1002/lipd.12377 · Cited by 9
Zhu, H., Zhang, M., Ye, Y., Liu, Z., Wang, J., Wu, X., & Lv, X. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115753 · Cited by 9
Sharma, R., Majee, C., Mazumder, R., Padhi, S., Khan, F., & Pal, R. S. (2024) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.58.1s.4 · Cited by 12
Mittal, A., Choudhary, N., Chaudhary, S., Kumari, A., Rastogi, A., Kumar, G., Maras, J. S., Sarin, S. K., & Sharma, S. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101565 · Cited by 9
Pan, T., Wu, S., Wang, S., Wang, X., Chen, D., & Chen, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113828 · Cited by 9
Single‐cell landscape of the intrahepatic ecosystem in alcohol‐related liver disease
Zhao, X., Wang, S., Liu, Q., Wei, W., Sun, X., Song, H., Xu, J., Zhang, S., Wang, H., & Fu, J. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70198 · Cited by 10
Serotonin Regulates Lipogenesis and Endoplasmic Reticulum Stress in Alcoholic Liver Disease
Hwang, I., Nam, J. E., Choi, W., Choi, W. G., Lee, E., Kim, H., Moon, Y.-A., Park, J. Y., & Kim, H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0215 · Cited by 9
Silencing FAF2 mitigates alcohol-induced hepatic steatosis by modulating lipolysis and PCSK9 pathway
Huda, N., Kusumanchi, P., Jiang, Y., Gao, H., Thoudam, T., Zeng, G., Skill, N. J., Sun, Z., Liangpunsakul, S., Ma, J., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000641 · Cited by 11
Chadha, P., Aghara, H., Johnson, D., Sharma, D., Odedara, M., Patel, M., Kumar, H., Thiruvenkatam, V., & Mandal, P. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108543 · Cited by 9
Zhao, Y., Xue, P., Zhong, Z., Pan, W., Zheng, J., Tian, X., & Han, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-02031-w · Cited by 9
Fan, Y., Dong, Z., Wu, Y., & Wen, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1692365 · Cited by 10
Liver specific, systemic and genetic contributors to alcohol-related liver disease progression
Schnabl, B., Arteel, G. E., Stickel, F., Hengstler, J. G., Vartak, N., Ghallab, A., Dooley, S., Li, Y., & Schwabe, R. F. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1714-9330 · Cited by 9
Roussey, B., Calame, P., Revel, L., Zver, T., Konan, A. N., Piton, G., Koch, S., Vuitton, L., & Delabrousse, É. (2022) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2022.03.008 · Cited by 9
P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis
Xia, G., Fang, Q., Cai, J.-N., Li, Z.-X., Zhang, F.-Z., & Lv, X. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00022 · Cited by 9
Jia-ga-song-tang protection against alcoholic liver and intestinal damage
Fang, J., Wu, Y., Gan, C., Ruan, S., He, X., Wang, B., Wang, Y., Yu, J., Sang, C., Zeren, D., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.981706 · Cited by 9
Litwinowicz, K., Waszczuk, E., Kuzan, A., Bronowicka-Szydełko, A., Gostomska‐Pampuch, K., Naporowski, P., & Gamian, A. (2022) · Nutrients · doi:10.3390/nu14245266 · Cited by 9
Zheng, L., Lu, Y., Wu, J., & Zheng, M. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.01.148 · Cited by 9
Nie, G., Che, J., Feng, Y., Liang, W., Chen, D., & Wang, H. (2023) · Dyes and Pigments · doi:10.1016/j.dyepig.2023.111535 · Cited by 9
Developing a Staging Scheme for Essential Tremor: A Discussion of Organizing Principles
Lenka, A., & Louis, E. D. (2023) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.812 · Cited by 11
Xia, G., Li, Z., Sheng, X., Xie, Z., Fang, Q., Zhang, C., Wang, T., Wang, Y., Wu, B., & Lv, X. (2023) · Food & Function · doi:10.1039/d3fo03685e · Cited by 9
Classification Algorithms for Liver Epidemic Identification
Makkena, K. R., & Natarajan, K. (2023) · EAI Endorsed Transactions on Pervasive Health and Technology · doi:10.4108/eetpht.9.4379 · Cited by 9
Xu, F., Chen, Z., Xie, L., Yang, S., Li, Y.-Y., Wu, J.-N., Wu, Y.-Y., Li, S., Zhang, X., Ma, Y., et al. (2023) · Aging · doi:10.18632/aging.205331 · Cited by 14
Chen, W., Zhang, Q., Ding, M., Yao, J., Guo, Y., Yan, W., Yu, S., Shen, Q., Huang, M., Zheng, Y., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109847 · Cited by 9
Wu, K., Liu, P.-P., Chen, M., Zhou, M., Liu, X., Yang, Q., Xu, L., & Gong, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.904557 · Cited by 9
Hohmann, N., Schröder, F., Moreira, B., Teng, H., Burhenne, J., Bruckner, T. M., Mueller, S., Haefeli, W. E., & Seitz, H. K. (2022) · Alcohol and Alcoholism · doi:10.1093/alcalc/agac068 · Cited by 9
Self-citationLiu, S., Zhao, Y., Xu, X., Wang, M., Tao, X., & Xu, H. (2022) · Journal of Applied Microbiology · doi:10.1093/jambio/lxac032 · Cited by 9
Yuan, Y., Wu, F., Zhang, F., Li, X., Wu, X., & Fu, J. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200562 · Cited by 9
Ding, Q., Guo, R., Hao, L., Song, Q., Fu, A., Lai, S., Xu, T., Zhuge, H., Chang, K., Chen, Y., et al. (2023) · Life Metabolism · doi:10.1093/lifemeta/load050 · Cited by 9
Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury
Neuman, M. G., Seitz, H. K., Teschke, R., Malnick, S. D. H., Johnson‐Davis, K. L., Cohen, L. B., German, A., Hohmann, N., Moreira, B., Moussa, G., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44030087 · Cited by 9
Self-citationGallstone and Gallbladder Disease: Biliary Tract and Cholangiopathies
Ceci, L., Han, Y., Krutsinger, K., Baiocchi, L., Wu, N., Kundu, D., Kyritsi, K., Zhou, T., Gaudio, E., Francis, H., et al. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220028 · Cited by 17
Macrophage heterogeneity in liver fibrosis
Wang, W., Li, S., Liu, Y., Ding, X., Yang, Y., Chen, S., Cao, J., Tacke, F., Dong, W., & Lan, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1639455 · Cited by 8
Sharma, R. R., Rashid, H., Bhat, A. M., Archoo, S., Gupta, R., & Abdullah, S. T. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114038 · Cited by 8
Zafar, Y., Siddiqi, A. K., Shaikh, N., Imran, M., Javaid, S. S., Manzoor, L., Iqbal, A. Z., & Petrášek, J. (2024) · Gastroenterology Research · doi:10.14740/gr1674 · Cited by 8
Liu, D., Yang, K., Li, T., Tang, T., Wang, Y., Wang, W., Li, J., Zhou, P., Wang, X., Zhao, C., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34214 · Cited by 8
Zhang, W., & Wong, R. J. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.06.001 · Cited by 8
Kan, M., Wang, R., Chen, L., Lv, X., Qiu, W., Zhang, H., Zhao, J., Li, M., Wen, X., Meng, X., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.006 · Cited by 9
Wei, S., Li, M., Zhao, L., Wang, T., Wu, K., Yang, J., Liu, Y., Zhao, Y., Du, F., Chen, Y., et al. (2024) · Chinese Medicine · doi:10.1186/s13020-024-01049-y · Cited by 8
Wang, T., Li, X., Xia, G., Gong, M., & Lv, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142395 · Cited by 8
NSun2 ‐Mediated tsRNAs Alleviate Liver Fibrosis via FAK Dephosphorylation
Li, P., Ying, S., Zou, Y., Wang, X., Zhang, R., Huang, C., Dai, M., Xu, K., Feng, G., Li, X., et al. (2025) · Cell Proliferation · doi:10.1111/cpr.70058 · Cited by 8
Innovative Strategies in the Diagnosis and Treatment of Liver Cirrhosis and Associated Syndromes
Sah, A. K., Afzal, M., Elshaikh, R. H., Abbas, A. M., Shalabi, M. G., Prabhakar, P. K., Babker, A. M. A., Khalimova, F., Sabrievna, V. A., & Choudhary, R. K. (2025) · Life · doi:10.3390/life15050779 · Cited by 16
Yang, K., Kim, K., Ryu, T., Shim, Y., Kim, H., Choi, S. E., Kim, M. J., Chung, K. P. S., Lee, E. M., Lee, K. W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60820-3 · Cited by 10
Hu, Y., Wang, Y., Li, X., Xie, Q., & Lyu, Z. (2025) · Food & Function · doi:10.1039/d5fo00915d · Cited by 8
The role of gallic acid in liver disease: a review of its phytochemistry, pharmacology, and safety
Li, P., Song, Y., Lv, L., Zhang, W., Jia, A., Dong, D., & Zhai, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1595508 · Cited by 10
Chen, J., Li, J., Ran, L., Yang, J., & Xie, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07177-9 · Cited by 8
Gao, Z., Wang, D., Zhang, H., Yang, J., Li, M., Lu, H., Shen, H., & Tang, Y. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.11.001 · Cited by 8
Cho, Y.-A., Ko, I., Jin, J., Hwang, L., Kim, S., Jeon, J. W., Yang, M. J., & Kim, C. (2022) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2244504.252 · Cited by 8
Yang, K., Ryu, T., & Chung, B. S. (2023) · Antioxidants · doi:10.3390/antiox12040841 · Cited by 8
Wu, D., Qin, L., Feng, C., Cao, L., Ye, J., Wu, X., Tan, D., & He, Y. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.105501 · Cited by 8
Oh, J., Kim, J., Lee, S., Park, G., Baritugo, K., Han, K. J., Lee, S., & Sung, G. (2024) · Metabolites · doi:10.3390/metabo14010039 · Cited by 8
Xu, T., Pan, Y., Ding, Q., Cao, F., Chang, K., Qiu, J., Zhuge, H., Hao, L., Wei, H., Si, C., et al. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00557-x · Cited by 8
Gwon, Y., Moon, C. Y., Lee, E., Im, S., & Kang, H. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106218 · Cited by 8
Zhao, Y.-X., Sun, Y.-Y., Li, L., Li, X., Li, H.-D., Chen, X., Xia, R., Yang, Y., Jiang, X., Zuo, L., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01333-5 · Cited by 8
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development
Todorović, N., Martinelli, S., Nannini, G., Weiskirchen, R., & Amedei, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413510 · Cited by 8
Construction of a NIR fluorescent probe for tracking mitochondrial HOCl during liver injury
Fan, C., Ma, K., Chen, R., Zhang, T., Song, Y., Liu, L., Chi, W., Dong, Q., Shu, W., & Zeng, C. (2025) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2025.113136 · Cited by 8
Peregud, D., Baronets, V. Y., Lobacheva, A. S., Ivanov, A. S., Сергеевна, А. О., Владимировна, Г. И., Kobalava, Z. D., Пирожков, С. В., & Теребилина, Н. Н. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.08.065 · Cited by 8
Tsopmejio, I. S. N., Ngueguim, F. T., Gounoue, R. K., Mbatchou, A., & Dimo, T. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2019-0370 · Cited by 8
Early‐life exposure to alcohol and the risk of alcohol‐induced liver disease in adulthood
Asiedu, B., Nyakudya, T. T., Lembede, B. W., & Chivandi, E. (2021) · Birth Defects Research · doi:10.1002/bdr2.1881 · Cited by 8
Src homolog and collagen homolog1 isoforms in acute and chronic liver injuries
Ma, H., Wang, C., Liu, X., Zhan, M., Wei, W., & Niu, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119302 · Cited by 8
Mörs, K., Sturm, R., Hörauf, J.-A., Kany, S., Cavalli, P., Omari, J., Powerski, M. J., Surov, A., Marzi, İ., Nowak, A. J., et al. (2021) · Disease Markers · doi:10.1155/2021/6622701 · Cited by 8
Testino, G., Vignoli, T., Patussi, V., Allosio, P., Amendola, M. F., Aricò, S., Baselice, A., Balbinot, P., Campanile, V., Fanucchi, T., et al. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07006-1 · Cited by 8
Shirai, D., Shinkawa, H., Takemura, S., Tanaka, S., Amano, R., Kimura, K., Kinoshita, M., Kawada, N., & Kubo, S. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102644 · Cited by 8
Chen, J., Martín‐Mateos, R., Li, J., Yin, Z., Chen, J., Lü, X., Glaser, K. J., Mounajjed, T., Yashiro, H., Siegelman, J., et al. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14699 · Cited by 8
Jo, S.-L., Baek, I., Ko, J., Kwun, H., Shin, H., & Hong, E. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00206.2022 · Cited by 8
Exosomal Long Noncoding RNAs Serve as Biomarkers for Liver Disease
Yang, Z., Tang, N., Zheng, M., & Chang, Y. (2023) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2023.22741 · Cited by 8
Metadata
- Authors
- Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H.
- Affiliations
- Heidelberg University (DE)
- University of Pittsburgh (US)
- National Institutes of Health (US)
- Hospital Clínic de Barcelona (ES)
- Medical University of Graz (AT)
- Inserm (FR)
- University of Southern California (US)
- ORCID
- Venue
- Nature Reviews Disease Primers
- Published
- 2018-08-16
- Volume
- 4
- Issue
- 1
- Pages
- 16-16
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4210980460
- Cited by
- 1,271
- References
- 244
- Citations by year
- 2026: 126 · 2025: 200 · 2024: 249 · 2023: 230 · 2022: 176 · 2021: 145 · 2020: 75 · 2019: 57 · 2018: 9
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-08-28)
- Open access
- closed
- Licence
- Locations
- Nature Reviews Disease Primers (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (IK6BX004205, I01 BX001991)
- National Institute on Alcohol Abuse and Alcoholism (R01AA011576)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- alcoholic liver disease, alcoholic fatty liver, alcoholic steatohepatitis, alcoholic hepatitis, liver cirrhosis, hepatocellular carcinoma, liver fibrosis, hepatic steatosis, oxidative stress, acetaldehyde toxicity, liver inflammation, alcoholism, liver fibrosis diagnosis, serum biomarkers, alcohol abstinence, liver transplantation
- MeSH terms
- Global Burden of Disease, Alcohol Drinking, Fatty Liver, Alcoholic, Humans, Liver Diseases, Alcoholic, Liver Neoplasms, Quality of Life, Liver Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review